Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Risk Descriptions Need To Be Standardized, FDA’s Galson Tells CERTs

Executive Summary

The standardization of risk expressions to compare drugs would be a desirable risk management tool, Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, suggested at a recent CERTs meeting

You may also be interested in...



FDA Should Validate Effectiveness Of Risk Management Tools, PhRMA Says

FDA risk management programs should be evaluated by the agency to determine the value of their implementation, the Pharmaceutical Research & Manufacturers of America maintained during a public workshop on risk management April 10

FDA Should Validate Effectiveness Of Risk Management Tools, PhRMA Says

FDA risk management programs should be evaluated by the agency to determine the value of their implementation, the Pharmaceutical Research & Manufacturers of America maintained during a public workshop on risk management April 10

Drug Benefit Defined By Dose-Response Relationships, CERTs Suggests

Establishing the correct dose-response relationship for drugs is crucial to defining drug benefit, the Centers for Education & Research on Therapeutics suggested

Related Content

UsernamePublicRestriction

Register

ID1130879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel